Clarifying State Action Immunity under the Antitrust Laws: FTC V. Phoebe Putney Health System, Inc

Angela M. Diveley
{"title":"Clarifying State Action Immunity under the Antitrust Laws: FTC V. Phoebe Putney Health System, Inc","authors":"Angela M. Diveley","doi":"10.2139/ssrn.2123677","DOIUrl":null,"url":null,"abstract":"The tension between federalism and national competition policy has come to a head. The state action doctrine finds its basis in principles of federalism, permitting states to replace free competition with alternative regulatory regimes they believe better serve the public interest. Public restraints have a unique ability to undermine the regime of free competition that provides the basis of U.S.- and state-commerce policies. Nevertheless, preservation of federalism remains an important rationale for protecting such restraints. The doctrine has elusive contours, however, which have given rise to circuit splits and overbroad application that threatens to subvert the state action doctrine’s dual goals of federalism and competition. The recent Eleventh Circuit decision in FTC v. Phoebe Putney Health System, Inc. epitomizes the concerns associated with misapplication of state action immunity. The U.S. Supreme Court recently granted the FTC’s petition for certiorari and now has the opportunity to more clearly define the contours of the doctrine. In Phoebe Putney, the FTC has challenged a merger it claims is the product of a sham transaction, an allegation certain to test the boundaries of the state action doctrine and implicate the interpretation of a two-pronged test designed to determine whether consumer welfare-reducing conduct taken pursuant to purported state authorization is immune from antitrust challenge. The FTC’s petition for writ of certiorari raises two issues for review. First, it presents the question concerning the appropriate interpretation of foreseeability of anticompetitive conduct. Second, the FTC presents the question whether a passive supervisory role on the state’s part can be construed as state action or whether its approval of the merger was a sham. In this paper, I seek to explicate the areas in which the state action doctrine needs clarification and to predict how the Court will decide the case in light of precedent and the principles underlying the doctrine.","PeriodicalId":82796,"journal":{"name":"St. Thomas law review","volume":"25 1","pages":"73"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"St. Thomas law review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/ssrn.2123677","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The tension between federalism and national competition policy has come to a head. The state action doctrine finds its basis in principles of federalism, permitting states to replace free competition with alternative regulatory regimes they believe better serve the public interest. Public restraints have a unique ability to undermine the regime of free competition that provides the basis of U.S.- and state-commerce policies. Nevertheless, preservation of federalism remains an important rationale for protecting such restraints. The doctrine has elusive contours, however, which have given rise to circuit splits and overbroad application that threatens to subvert the state action doctrine’s dual goals of federalism and competition. The recent Eleventh Circuit decision in FTC v. Phoebe Putney Health System, Inc. epitomizes the concerns associated with misapplication of state action immunity. The U.S. Supreme Court recently granted the FTC’s petition for certiorari and now has the opportunity to more clearly define the contours of the doctrine. In Phoebe Putney, the FTC has challenged a merger it claims is the product of a sham transaction, an allegation certain to test the boundaries of the state action doctrine and implicate the interpretation of a two-pronged test designed to determine whether consumer welfare-reducing conduct taken pursuant to purported state authorization is immune from antitrust challenge. The FTC’s petition for writ of certiorari raises two issues for review. First, it presents the question concerning the appropriate interpretation of foreseeability of anticompetitive conduct. Second, the FTC presents the question whether a passive supervisory role on the state’s part can be construed as state action or whether its approval of the merger was a sham. In this paper, I seek to explicate the areas in which the state action doctrine needs clarification and to predict how the Court will decide the case in light of precedent and the principles underlying the doctrine.
澄清反垄断法下的国家行动豁免:联邦贸易委员会诉菲比普特尼卫生系统公司
联邦制和国家竞争政策之间的紧张关系已经到了极点。国家行为原则以联邦制原则为基础,允许各州用他们认为更有利于公众利益的其他监管制度来取代自由竞争。公共限制具有破坏自由竞争制度的独特能力,而自由竞争制度是美国和各州商业政策的基础。然而,保留联邦制仍然是保护这些限制的重要理由。然而,该原则有难以捉摸的轮廓,这导致了巡回分裂和过度广泛的应用,有可能颠覆州行动原则的联邦制和竞争的双重目标。最近,在联邦贸易委员会诉菲比·普特尼卫生系统公司案中,第十一巡回法院的判决集中体现了对滥用国家行为豁免的担忧。美国最高法院最近批准了联邦贸易委员会的调卷申请,现在有机会更清楚地界定这一原则的轮廓。在菲比·普特尼案中,联邦贸易委员会对它声称是虚假交易的产物的合并提出了质疑,这一指控肯定会考验国家行为原则的界限,并暗示对双管齐下的测试的解释,该测试旨在确定根据所谓的国家授权采取的减少消费者福利的行为是否免于反垄断挑战。联邦贸易委员会对调卷令的请愿提出了两个需要审查的问题。首先,它提出了关于反竞争行为可预见性的适当解释的问题。其次,联邦贸易委员会提出的问题是,国家方面的被动监督角色是否可以被解释为国家行为,或者它对合并的批准是否是虚假的。在本文中,我试图解释国家行为原则需要澄清的领域,并预测法院将如何根据先例和原则来决定案件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信